61 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 61 of 61 clinical reviews.
A guide to acne vulgaris, male and female pattern hair loss, telogen effluvium, and alopecia areata. Covers FDA-approved drugs, off-label options, evidence quality, and when to seek in-person care.
A guide to adolescent acne covering pathophysiology, evidence-based treatments (topical and systemic), hormonal therapies, hair loss in teens, pregnancy-safe options, and postmenopausal skin changes.
A clinical guide to alopecia areata covering autoimmune causes, JAK inhibitor therapies (baricitinib, ritlecitinib), corticosteroid injections, differential diagnosis from other hair loss types, and long-term management.
A guide to atopic dermatitis diagnosis, current systemic and biologic therapies, and the skin-hair overlap conditions including alopecia areata, telogen effluvium, and androgenetic alopecia.
A guide to azelaic acid for acne, rosacea, and hyperpigmentation. Covers FDA-approved formulations, combination therapy with tretinoin and adapalene, side effects, and who qualifies for prescription strength.
Benzoyl peroxide up to 5% is considered safe in pregnancy, alongside azelaic acid. Isotretinoin and oral tetracyclines after 15 weeks are contraindicated.
Evidence-based guide to bimatoprost (Latisse), tretinoin (Retin-A), tazarotene (Tazorac), adapalene (Differin), and trifarotene (Aklief), doses, mechanisms, clinical trial data, and how to choose.
What does compounded topical finasteride actually cost? We break down pharmacy pricing, insurance coverage, compounding fees, and how it compares to oral finasteride and other hair loss treatments.
How much does oral minoxidil cost? Generic tablets typically run $10-$30 a month before discounts, with compounded low-dose versions costing more. Insurance rarely covers it because the hair-loss use is off-label.
Crisaborole cleared skin in about a third of patients by day 29 in trials. See how this steroid-free eczema ointment compares to other treatments.
A guide to cystic acne covering isotretinoin, hormonal therapy, antibiotics, and emerging treatments with clinical trial data and dosing protocols.
Differin (adapalene) belongs to the retinoid drug class, not corticosteroids or calcineurin inhibitors. See how this third-gen retinoid treats acne.
Evidence-based answers on collagen supplements for skin, oral and topical minoxidil for women, finasteride and PFS risk, and the real Accutane timeline. Written by the HealthRX.com medical team.
An evidence-based look at post-finasteride syndrome: what the clinical data shows, the nocebo debate, FDA warnings, risk factors, and what men considering finasteride for hair loss need to know.
Minoxidil is the only FDA-approved topical treatment for female pattern hair loss. Learn how it works, expected timelines, oral vs. topical options, side effects, and what clinical trials show about efficacy in women.
Dupixent blocks IL-4 and IL-13 for eczema, asthma, nasal polyps, and more. See FDA-approved uses, adult dosing, trial results, and side effects.
Dupixent causes conjunctivitis in about 10% to 28% of AD patients, usually mild. Learn onset timing, severity, and how eye drops resolve it.
Dutasteride (Avodart) inhibits both type 1 and type 2 5-alpha reductase, reducing scalp DHT by roughly 90%. This guide covers off-label use for androgenetic alopecia, head-to-head data versus finasteride, dosing, side effects, and what to expect.
Gubelin 2014 RCT: dutasteride 0.5 mg beat finasteride 1 mg on hair count at 24 weeks, with higher sexual side effects and longer half-life; no data beyond 5 years.
FPHL vs telogen effluvium explained. Minoxidil is FDA-approved; spironolactone and low-dose oral minoxidil are common off-label options.
Female pattern hair loss affects 40-50% of women by 50, causing crown thinning. Learn Ludwig staging, causes, and minoxidil-based treatment options.
A guide covering hirsutism, male pattern hair loss, female pattern hair loss, telogen effluvium, and alopecia areata, including FDA-approved treatments, diagnostic criteria, and what remains uncertain in the evidence.
A guide to realistic treatment timelines for isotretinoin (Accutane), minoxidil, finasteride, and tretinoin, with specific trial data, dosing benchmarks, and safety facts.
4% hydroquinone cream lightens skin in 8 to 12 weeks. See dosing, the 3 to 6 month use limit, and how it compares to tretinoin and adapalene.
Hyperpigmentation forms from excess melanin; first-line treatment pairs hydroquinone with tretinoin and daily SPF 30+, showing improvement in 8-12 weeks.
Microneedling for hair loss shows strong clinical evidence when combined with minoxidil or finasteride. Review of trials, needle depths, protocols, and expected regrowth timelines.
A guide to the long-term safety of oral minoxidil for hair loss, covering cardiovascular effects, fluid retention, hypertrichosis, real trial data, and how it compares to topical minoxidil.
A guide to isotretinoin (Accutane), tretinoin (Retin-A), adapalene (Differin), tazarotene (Tazorac), and trifarotene (Aklief), covering efficacy, dosing, side effects, and how to choose the right retinoid.
How to calculate your isotretinoin cumulative dose by weight, what low-dose oral minoxidil looks like in practice, and how compounded topical finasteride compares to oral. Written by the HealthRX.com medical team.
A clinical comparison of isotretinoin and spironolactone for acne, plus finasteride vs dutasteride, topical vs oral minoxidil, tretinoin vs retinol, and PRP vs minoxidil for hair loss. Evidence-based guidance from the HealthRX.com medical team.
A complete clinical guide to isotretinoin's teratogenic risks, the iPLEDGE REMS program requirements, monthly pregnancy testing, contraception mandates, and what happens if a pregnancy occurs during treatment.
A guide to androgenetic alopecia in men covering DHT biology, Norwood staging, FDA-approved drugs (finasteride, minoxidil, dutasteride), emerging therapies, and when to consider hair transplantation.
Evidence-based guide to melasma causes, first-line treatments like triple combination cream and tranexamic acid, sunscreen protocols, and when to see a dermatologist.
Evidence-based guide to male pattern hair loss covering FDA-approved treatments like finasteride and minoxidil, emerging therapies, and when to see a specialist.
Oral finasteride (Propecia) is an FDA-approved 5-alpha reductase inhibitor for male pattern hair loss. Learn about dosing, clinical trial results, side effects, and how it compares to topical alternatives.
A guide to low-dose oral minoxidil for androgenetic alopecia and other hair loss types, covering doses, efficacy data, side effects, and how it compares to topical minoxidil.
A guide to the oral minoxidil low dose protocol for hair loss, covering 0.25 to 5 mg dosing tiers, evidence from randomized trials, compounded topical finasteride, and isotretinoin weight-based dosing.
Low-dose oral minoxidil (1.25-5 mg) has quietly displaced topical minoxidil in dermatology practice. The HealthRX.com Medical Team argues the evidence base and safety profile at these doses justify making oral the first-line choice for most adults with androgenetic alopecia.
A comparison of PRP therapy vs minoxidil for hair loss, plus finasteride vs dutasteride, topical vs oral minoxidil, and tretinoin vs retinol. Includes trial data, dosing, and a decision framework.
A guide to psoriasis covering pathophysiology, FDA-approved systemic and biologic therapies, and how psoriasis overlaps with scalp hair loss conditions including telogen effluvium and alopecia areata.
A guide to rosacea subtypes, male and female pattern hair loss, telogen effluvium, and alopecia areata. Includes FDA-approved treatments, dosing details, and clinical trial data.
A guide to prescription and evidence-based treatments for skin aging, hair loss, and medical aesthetics, including tretinoin, minoxidil, GHK-Cu peptides, PRP, and GLP-1 effects on skin quality.
Spironolactone treats hormonal hair loss and acne in women by blocking androgens. Learn how it works, what the evidence shows, and how topical retinoids like tretinoin, adapalene, tazarotene, and trifarotene complement skin goals.
A guide to tazarotene (Tazorac) covering acne, photoaging, and psoriasis indications, head-to-head comparisons with tretinoin, adapalene, and trifarotene, dosing protocols, and side-effect management.
Telogen effluvium causes diffuse hair shedding 2-3 months after a trigger. Learn how TE differs from pattern hair loss and alopecia areata, what treatments work, and when hair regrows.
Off-label tofacitinib (5mg twice daily or 11mg XR) regrows hair in 50-77% of alopecia areata patients within 3-6 months, but relapse after stopping is common.
A guide to topical clindamycin for acne, including combination therapy with tretinoin, adapalene, tazarotene, and trifarotene, plus resistance data and prescribing details.
A guide to topical dapsone gel for acne, including clinical trial data, dosing, side effects, and head-to-head comparisons with tretinoin, adapalene, tazarotene, and trifarotene.
Compounded topical finasteride uses 0.1% to 0.25% strength, cuts systemic DHT reduction to about 25%-30%, and needs 6-12 months for visible results.
Topical finasteride cuts scalp DHT 30-40% with far less serum DHT suppression than oral pills. See concentrations, onset time, and side effect data.
Topical minoxidil is OTC for hair loss; needs daily use for 16+ weeks and ongoing use to keep results. See dosing, results, and how it compares to other topical Rx.
Oral minoxidil (0.625-5mg) may grow slightly more hair than topical 5%, but adds cardiovascular risks topical avoids. Compare doses, efficacy, and side effects.
Topical steroid withdrawal (TSW) causes rebound redness, burning, and skin shedding after stopping long-term topical corticosteroids. Learn the symptoms, risk factors, recovery timeline, and steroid-sparing alternatives like dupilumab.
A guide to topical corticosteroid potency classes, from OTC hydrocortisone (Class VII) to prescription clobetasol (Class I), plus how topical retinoids like tretinoin, adapalene, tazarotene, and trifarotene fit into dermatologic care.
A clinical guide to tirbanibulin (Klisyri) for actinic keratosis, including mechanism, efficacy data from KX01-AK-003/004, and comparisons with tretinoin, tazarotene, adapalene, and trifarotene.
Tralokinumab (Adbry) is an IL-13 inhibitor approved for moderate-to-severe atopic dermatitis in adults. Learn about dosing, trial results, side effects, and how it compares to dupilumab.
A guide to tretinoin (Retin-A), comparing it with adapalene, tazarotene, trifarotene, and topical minoxidil. Covers doses, timelines, side effects, and how to build a retinoid regimen that works.
A clinical comparison of tretinoin and retinol for skin health, covering potency, efficacy data, side effects, and how to choose the right retinoid for your goals.
Trifarotene (Aklief) is the only FDA-approved topical retinoid selective for the RAR-γ receptor, proven in two Phase 3 trials to clear trunk and facial acne. Learn how it compares to tretinoin, tazarotene, and adapalene, who qualifies, and how to start safely.
Upadacitinib (Rinvoq) 15mg or 30mg daily got 70% of patients to EASI 75 by week 16, outperforming dupilumab head-to-head, with itch relief in 1-2 days.
Showing the first 60 matches. Use search or filters to narrow the library.